Reports for CAELYX

Brand name
CAELYX

Company Name

BAXTER CORPORATION

Drug Identification Number

02238389

Ingredients & Strength

ATC Code

  • L01DB

ATC Descriptor

  • CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES

Status

MARKETED
Shortage reports
Brand name Packaging size Status Date Created Date Updated Reports
CAELYX BX411008 CAELYX (Liposomal Doxorubicin), 20mg / 10mL vial Resolved 2024-06-06 2024-08-30 229782

Showing 1 to 1 of 1

Discontinuation reports
Brand name Packaging size Status Date Created Date Updated Reports

Showing 1 to 0 of 0